{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":40,"n_cols":5,"rows_kept":40,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[33,2,33,3],[34,2,34,3],[37,2,37,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910780301103321"]
[null,null,"Autore",null,"Staff Institute of Medicine"]
[null,null,"Titolo",null,"Assessment of the CDC Anthrax vaccine safety and efficacy research program [[electronic resource]]"]
[null,null,"Pubbl/distr/stampa",null,"Washington, : National Academies Press, 2002"]
[null,null,"ISBN",null,"0-309-50374-4"]
[null,null,"Descrizione fisica",null,"1 online resource (179 p.)"]
[null,null,"Disciplina",null,"615"]
[null,null,"Soggetti",null,"Anthrax -- Vaccination"]
[{"$nulls":4},"Public health"]
[{"$nulls":4},"Anthrax - Vaccination - Research - United States"]
[{"$nulls":4},"Bacterial Vaccines"]
[{"$nulls":4},"Evaluation Studies as Topic"]
[{"$nulls":4},"Health Care Evaluation Mechanisms"]
[{"$nulls":4},"Quality of Health Care"]
[{"$nulls":4},"Bacillaceae Infections"]
[{"$nulls":4},"Investigative Techniques"]
[{"$nulls":4},"Vaccines"]
[{"$nulls":4},"Health Services Administration"]
[{"$nulls":4},"Gram-Positive Bacterial Infections"]
[{"$nulls":4},"Bacterial Infections"]
[{"$nulls":4},"Health Care Quality, Access, and Evaluation"]
[{"$nulls":4},"Health Care"]
[{"$nulls":4},"Biological Products"]
[{"$nulls":4},"Complex Mixtures"]
[{"$nulls":4},"Bacterial Infections and Mycoses"]
[{"$nulls":4},"Diseases"]
[{"$nulls":4},"Program Evaluation"]
[{"$nulls":4},"Drug Evaluation"]
[{"$nulls":4},"Anthrax"]
[{"$nulls":4},"Anthrax Vaccines"]
[{"$nulls":4},"Public Health"]
[{"$nulls":4},"Health & Biological Sciences"]
[{"$nulls":4},"Communicable Diseases"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"\"\"Front Matter\"\"; \"\"Preface\"\"; \"\"Reviewers\"\"; \"\"Contents\"\"; \"\"Figures, Tables, and Boxes\"\"; \"\"Abbreviations and Acronyms\"\"; \"\"Executive Summary\"\"; \"\"1 Introduction\"\"; \"\"2 Background\"\"; \"\"3 The CDC Anthrax Vaccine Research Plan\"\"; \"\"4 Proposed Studies on the Efficacy of the Anthrax Vaccine\"\"; \"\"5 Proposed Studies on the Safety of the Anthrax Vaccine\"\"; \"\"6 Proposed Studies on the Acceptability of the Anthrax Vaccine\"\"; \"\"7 Summary Assessment of the CDC Anthrax Vaccine Research Plan\"\"; \"\"Appendix A Biographical Sketches\"\"; \"\"Appendix B Information-Gathering Meeting Agendas\"\""]
[{"$nulls":4},"\"\"Appendix C Anthrax Vaccine Safety & Efficacy Research Plan\"\"\"\"Appendix D Food and Drug Administration Final Rule: New Drug and Biological Drug Products;  Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible\"\"; \"\"Appendix E Department of Defense Memorandum: Reintroduction of the Anthrax Vaccine Immunization Program\"\"; \"\"Appendix F Institute of Medicine: CDC Anthrax Vaccine Safety & Efficacy Research Program. Interim Report Findings and Recommendations1\"\""]
[{"$nulls":4},"\"\"Appendix G Institute of Medicine: The Anthrax Vaccine: Is It Safe? Does It Work? Findings and Recommendations1\"\""]